About Stability Biologics
Stability Biologics is a Healthcare company based in Nashville (United States) founded in 2010, and was acquired by MiMedx Group in January 2016. Bone and skin tissues are developed for medical grafting applications. Stability Biologics offers products and services including AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its legal entity is STABILITY BIOLOGICS, LLC. Its competitors include Avidity Biosciences, Humacyte and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2010 in Nashville, United States, Stability Biologics operates in the tissue engineering sector. Bone tissue and demineralized bone matrix are manufactured for grafting procedures, alongside split-thickness skin grafts for burn treatment and traditional allograft cancellous bone products. Operations began as an FDA-registered tissue bank, with a merger to MiMedx occurring in 2016 to expand biomaterials capabilities.
- Headquarters Nashville, United States
- Stage Acquired
- SectorsHealthcare
- Website stabilitybio.com
- Social LinkedIn X
- Acquired by MiMedx Group (Jan 2016)
- Legal Name Stability Biologics, Llc
- Investors
- Acquired byMiMedx Group
(Jan 2016)
Products & Services of Stability Biologics
Stability Biologics offers a comprehensive portfolio of products and services, including AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips.
Advanced allograft for regenerative medicine and tissue repair applications.
Specialized allograft for surgical wound healing and patient care.
Allograft designed for burn treatment and skin regeneration processes.
Material for bone grafting in medical and regenerative procedures.
Chips used for bone repair and structural support in surgeries.
Investors in Stability Biologics
Stability Biologics has secured backing from 1 investor. Prominent investors backing the company include MiMedx Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | mimedx.com | Marietta, United States |
Investor details for Stability Biologics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Stability Biologics
2 dated milestones of Stability Biologics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Stability Biologics is founded.
- Exit Acquired by MiMedx Group.
Competitors of Stability Biologics
Stability Biologics has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Humacyte and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| humacyte.com | 2004 | Morrisville, United States | $424.76M | 70 | Human tissue-based products are developed for vascular disease applications. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of Stability Biologics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Stability Biologics
The website of Stability Biologics (stabilitybio.com) receives about 2K visits a month.
- Monthly visits2K
▼ 18.1% vs previous month
Websites whose visitors overlap most with Stability Biologics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Stability Biologics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stability Biologics
Stability Biologics was founded in 2010.
Stability Biologics is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Founded in 2010 in Nashville, United States, Stability Biologics operates in the tissue engineering sector. Bone tissue and demineralized bone matrix are manufactured for grafting procedures, alongside split-thickness skin grafts for burn treatment and traditional allograft cancellous bone products. Operations began as an FDA-registered tissue bank, with a merger to MiMedx occurring in 2016 to expand biomaterials capabilities.
Stability Biologics's top competitors include Humacyte, Avidity Biosciences and Vividion Therapeutics.
Stability Biologics offers AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips.
Stability Biologics has 1 investor. Key investors include MiMedx Group.
Stability Biologics operates through Stability Biologics, Llc.
Yes. Stability Biologics was acquired by MiMedx Group in January 2016.